• SpaceAge Labs

  Led · Seed · Mar 2022

  SpaceAge Labs develops remoteEye, a sensor-agnostic IoT/AI platform for connected operations and maintenance that combines low‑power rEye IoT Nodes, low‑cost long‑range wireless networks and an enterprise-grade rEye Data Cloud. rEye IoT Nodes read and transmit data from industrial sensors, while the wireless networks cost as little as S$1 per month per device, support multi‑kilometre range and up to five years of battery life. The rEye Data Cloud stores, analyses and visualises sensor data with proprietary AI and geospatial analysis accessible via web or mobile. The company is initially targeting Water/Wastewater, Urban Greenery/Landscaping and Facilities Management sectors. SpaceAge Labs plans to use its recent seed funding to grow its team, expand internationally and roll out pilot projects across Singapore, Australia and the U.S. It is supported by NUS Enterprise, Imagine H2O and PUB’s Singapore Water Exchange, and works with Planetspark (an Excelpoint subsidiary) as a partner and investor.

• Aevice Health

  Participated · Series A · Jun 2021

  Aevice Health is a Singapore-based medical technology company. Regulatory filings indicate the company has secured $7 million in a seed-plus (seed extension) funding round. The published report does not provide details about the company's specific products, services, or operating metrics. No investor names, previous rounds, valuation, or use of proceeds were disclosed in the article. The fundraising information is cited from regulatory filings reported by the publication. Aevice Health is a Singapore-based provider of remote respiratory monitoring solutions built around its flagship device, the AeviceMD. The AeviceMD is FDA-cleared and HSA-approved for remote respiratory monitoring. On 15 May 2024 the company announced a US$1.0 million investment from A&D Company to accelerate digital health initiatives. The funding is intended to support extension of AeviceMD into the US and Japan markets and further product deployment. The collaboration gives Aevice access to A&D Company's medical-technology expertise and network while allowing A&D to leverage Aevice's technology to create new healthcare solutions. JETRO Singapore fostered the partnership; the LinkedIn announcement named Adrian Ang, Rex X. Tan and the team. Aevice Health is a Singapore-based medical technology spin-off from Nanyang Technological University that develops non-invasive wearable devices for early detection of cardiopulmonary illnesses. Its flagship product, AeviceMD, is an AI-powered wearable stethoscope placed on the chest to continuously listen in real time and detect cardiopulmonary abnormalities such as wheezing. The company raised S$2.8 million (US$2.1 million) in a pre-Series A round participated by Toho Holdings, Pureland Group Venture, Silicon Solutions Partners, AIP Ventures and SEEDS Capital. Proceeds will be used to further develop its proprietary technology and expand its remote respiratory monitoring solution into Japan to augment the country’s telehealth landscape. Aevice Health has entered a strategic partnership with Tokyo-listed Toho Holdings to develop and market AeviceMD in Japan, and last year signed a partnership with The Health Bank Global to expand into the Middle East, North Africa and South Asia. The company aims to advance remote patient monitoring and enable continuous, remote self-management of chronic respiratory diseases for hospitals, insurers, pharmaceutical companies and health systems.

No current team members are available.